Notice Type
Departmental
Consent to the Distribution of a New Medicine Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Calcium chloride (dihydrate) 0.48 mg/mL, magnesium chloride (hexahydrate) 0.3 mg/mL, potassium chloride 0.75 mg/mL, sodium acetate (trihydrate) 3.9 mg/mL, sodium chloride 6.4 mg/mL, sodium citrate (dihydrate) 1.7 mg/mL Irrigation, eye Laboratoire Chauvin SA., Aubenas (Ardeche), France Aqsia Desogestrel 0.075 mg Tablet, film coated Organon International BV., Oss, The Netherlands Cerazette Calcium folinate (anhydrous) 10.8 mg/mL equivalent to 10 mg/mL folinic acid Injection, solution Pharmacia & Upjohn (Perth) Pty Limited, Bentley, Western Australia, Australia Leucovorin Calcium Bovine serum 0.6 g, goat anti-mouse polyclonal antibody 4.9 g, murine monoclonal antibody to alpha HCG 0.9 g, murine monoclonal antibody to beta HCG 1.8 g Test kit, pregnancy Syntron Bioresearch Inc., Vista, California, United States of America Perfectly Clear Midstream Pregnancy Test Bovine serum 1 g, goat anti-mouse polyclonal antibody 8 g, murine monoclonal antibody to alpha HCG 1.5 g, murine monoclonal antibody to beta HCG 3 g Test kit, pregnancy Syntron Bioresearch Inc., Vista, California, United States of America Perfectly Clear Pregnancy Test Strip Chromium trichloride (anhydrous) 20.4 g/mL, copper chloride (dihydrate) 536 g/mL, manganese chloride 288 g/mL, zinc chloride 2,084 g/mL Injection, concentrate David Bull Laboratories Limited, Mulgrave North, Victoria, Australia Trace Elements Iopamidol 498.72 mg/mL equivalent to 240 mg/mL iodine Injection, solution Schering AG., Berlin, Germany Ultravist 240 Dated this 3rd day of June 1999. G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.
Publication Date
10 Jun 1999

Notice Number

1999-go4117

Page Number

1545